Sector Update: Health Care

MT Newswires04:42

Emergent BioSolutions Wins $50 Million Contract Option for Cyfendus; Shares Rise

MT Newswires00:37

Express News | Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025

BreakingsDec 16 21:00

Express News | Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)

BreakingsDec 16 21:00

Investors Don't See Light At End Of Emergent BioSolutions Inc.'s (NYSE:EBS) Tunnel And Push Stock Down 26%

Simply Wall StDec 10 18:20

Emergent BioSolutions Inc.'s (NYSE:EBS) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains

Simply Wall StDec 8 20:41